Cite
MLA Citation
Niveditha Devasenapathy et al.. “Cancer risk with topical calcineurin inhibitors, pimecrolimus and tacrolimus, for atopic dermatitis: a systematic review and meta-analysis.” Lancet, vol. 7, 2023, pp. 13–25. http://access.bl.uk/ark:/81055/vdc_100172523492.0x000007